Journal of Viral Hepatitis · 1996 · 127 citations · 18 references
PharmacyInfectious DiseasesPharmacotherapyHepatitis PharmacotherapyHepatologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyViral HepatitisViral Hepatitis TreatmentChronic Viral HepatitisDna Virus ReplicationHbv Dna SuppressionHepatitis B TherapyHepatitis B Virus PersistenceHepatitis B Virus Replication
This is the first double-blind controlled study of famciclovir, an oral antiviral agent, as potential therapy for chronic hepatitis B virus (HBV) carries. A fall of more than 90% in HBV DNA levels was noted in six of 11 evaluable patients treated with a 10 day course of oral famciclovir. Further studies with more prolonged therapy are ongoing.
18
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang et al. · The Lancet · 1981 · 2.9K citations
David L. Earnshaw, T. H. Bacon, Sarah J. Darlison et al. · Antimicrobial Agents and Chemotherapy · 1992 · 233 citations · Full text